Lane HY - Search Results

1

Genome-wide association studies in pharmacogenomics of antidepressants.

Lin E, Lane HY. Lin E, et al. Among authors: lane hy. Pharmacogenomics. 2015;16(5):555-66. doi: 10.2217/pgs.15.5. Pharmacogenomics. 2015. PMID: 25916525 Review.

2

Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics.

Lane HY, Lee CC, Liu YC, Chang WH. Lane HY, et al. Pharmacogenomics. 2005 Mar;6(2):139-49. doi: 10.1517/14622416.6.2.139. Pharmacogenomics. 2005. PMID: 15882132 Review.

3

Genome-wide association study of bipolar I disorder in the Han Chinese population.

Lee MT, Chen CH, Lee CS, Chen CC, Chong MY, Ouyang WC, Chiu NY, Chuo LJ, Chen CY, Tan HK, Lane HY, Chang TJ, Lin CH, Jou SH, Hou YM, Feng J, Lai TJ, Tung CL, Chen TJ, Chang CJ, Lung FW, Chen CK, Shiah IS, Liu CY, Teng PR, Chen KH, Shen LJ, Cheng CS, Chang TP, Li CF, Chou CH, Chen CY, Wang KH, Fann CS, Wu JY, Chen YT, Cheng AT. Lee MT, et al. Among authors: lane hy. Mol Psychiatry. 2011 May;16(5):548-56. doi: 10.1038/mp.2010.43. Epub 2010 Apr 13. Mol Psychiatry. 2011. PMID: 20386566

4

Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.

Hung CC, Chiou MH, Huang BH, Hsieh YW, Hsieh TJ, Huang CL, Lane HY. Hung CC, et al. Among authors: lane hy. Pharmacogenomics. 2011 Nov;12(11):1525-33. doi: 10.2217/pgs.11.96. Epub 2011 Sep 8. Pharmacogenomics. 2011. PMID: 21902500

5

Assessing gene-gene interactions in pharmacogenomics.

Lane HY, Tsai GE, Lin E. Lane HY, et al. Mol Diagn Ther. 2012 Feb 1;16(1):15-27. doi: 10.1007/BF03256426. Mol Diagn Ther. 2012. PMID: 22352452 Review.

6

Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.

Huang CC, Wei IH, Huang CL, Chen KT, Tsai MH, Tsai P, Tun R, Huang KH, Chang YC, Lane HY, Tsai GE. Huang CC, et al. Among authors: lane hy. Biol Psychiatry. 2013 Nov 15;74(10):734-41. doi: 10.1016/j.biopsych.2013.02.020. Epub 2013 Apr 3. Biol Psychiatry. 2013. PMID: 23562005 Clinical Trial.

7

Highlights from the latest articles in pharmacogenomics of antipsychotics.

Lin E, Lane HY. Lin E, et al. Among authors: lane hy. Pharmacogenomics. 2014 Mar;15(4):415-7. doi: 10.2217/pgs.14.9. Pharmacogenomics. 2014. PMID: 24624908 No abstract available.

8

Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.

Lin CY, Tsai GE, Wang HS, Wu YH, Chiou CC, Wu VY, Lane HY. Lin CY, et al. Among authors: lane hy. J Clin Psychiatry. 2014 Sep;75(9):e924-31. doi: 10.4088/JCP.13m08843. J Clin Psychiatry. 2014. PMID: 25295435

9

Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy.

Lin CH, Chen MC, Yang WC, Lane HY. Lin CH, et al. Among authors: lane hy. Eur Neuropsychopharmacol. 2016 Feb;26(2):225-233. doi: 10.1016/j.euroneuro.2015.12.019. Epub 2015 Dec 11. Eur Neuropsychopharmacol. 2016. PMID: 26718791

10

Antidepressants in association with reducing risk of oral cancer occurrence: a nationwide population-based cohort and nested case-control studies.

Chung CM, Kuo TM, Chiang SL, Wang ZH, Hung CC, Lane HY, Liu CS, Ko YC. Chung CM, et al. Among authors: lane hy. Oncotarget. 2016 Mar 8;7(10):11687-95. doi: 10.18632/oncotarget.7049. Oncotarget. 2016. PMID: 26840257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page